Compare IDEXX Laboratories, Inc. (IDXX) vs NRG Energy Inc (NRG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs NRG Energy Inc — how do they compare? IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B), while NRG Energy Inc trades at $107.97 (market cap $22.35B). The key difference: IDEXX Laboratories, Inc. is the larger of the two by market cap, and NRG Energy Inc pays a 1.79% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold IDEXX Laboratories, Inc. for 46 Days and NRG Energy Inc for 63 Days on average.
| IDXX | NRG | |
|---|---|---|
Market Cap | $40.43B | $22.35B |
Volume | 692,164 | 5,011,942 |
Sector | Health | Utilities |
52-Week High | $766.68 | $184.03 |
52-Week Low | $504.70 | $95.23 |
Typical Hold Time | 46 Days | 63 Days |
Enterprise Value | $41.32B | $46.30B |
Dividend Yield | — | 1.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $518.00, up 2.24% with strong earnings beats in recent quarters. The stock shows bearish technical signals but maintains robust fundamentals with 25.03% net margins and 74.21% ROE. Recent acquisitions like CoVetAI and product expansions highlight growth initiatives. Analyst consensus remains bullish with a $665 price target, though technical indicators suggest near-term caution.
Outlook remains positive driven by diagnostic innovation and recurring revenue growth, but faces headwinds from FX volatility and weaker U.S. vet visits. The 36.06 P/E ratio reflects premium valuation, requiring sustained execution. Risks include competitive pressures and insider selling, while institutional ownership trends show mixed signals.
NRG Energy trades at $107.97, down 0.59% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q2 2026 earnings of $1.49 per share, missing expectations of $1.69, though revenue growth remains positive with 2026 projections at $33.1 billion. Recent developments include a landmark 1.2 GW Texas data center power project and the acquisition of LS Power assets, positioning for growth in hyperscale computing demand.
The investment outlook is cautiously optimistic with strong analyst support (70% buy ratings) and a consensus price target of $202.90 offering significant upside. However, recent earnings misses, rising debt levels (56.42% debt-to-asset ratio in 2025), and execution risks on major capital projects present near-term challenges. The stock's valuation appears reasonable with P/E of 27.69 and P/S of 0.65 relative to sector peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →
